東材科技(601208.SH):擬發行可轉債募資不超14億元 用於年產25000噸偏光片用光學級聚酯基膜項目等
格隆匯3月31日丨東材科技(601208.SH)公佈公開發行可轉換公司債券預案,此次擬發行可轉債總額不超過人民幣14億元(含14億元),具體數額提請股東大會授權公司董事會或董事會授權人士在上述額度範圍內確定。
此次公開發行可轉換公司債券募集資金總額不超過14億元(含14億元),扣除發行費用後,募集資金用於東材科技成都創新中心及生產基地項目(一期)、東材科技成都創新中心及生產基地項目(二期)、年產25000噸偏光片用光學級聚酯基膜項目、年產20000噸超薄MLCC用光學級聚酯基膜技術改造項目及補充流動資金等。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.